Tabalumab - CAS 1143503-67-6

Tabalumab (LY2127399) is a humanised monoclonal antibody targeting BAFF that neutralises both soluble and membrane-bound forms of BLyS and affects B-cell populations, and can be used for research into autoimmune diseases such as rheumatoid arthritis, kidney failure, and systemic lupus erythematosus.

TNF

Apoptosis

1143430

0.98

-20°C

Ice Packs

Inhibitory Antibodies